Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome

Medicine & Life Sciences

• Li-Fraumeni Syndrome 100%
• Germ-Line Mutation 73%
• Myelodysplastic Syndromes 73%
• Cytogenetics 23%
• Acute Myeloid Leukemia 23%
• Molecular Pathology 18%
• Radiotherapy 11%
• Chromosomes, Human, Pair 5 10%
• Neoplasms 10%
• Pancytopenia 10%
• Cytogenetic Analysis 9%
• p53 Genes 8%
• Karyotype 8%
• Glioblastoma 7%
• Chromosome Aberrations 7%
• Registries 6%
• Bone Marrow 5%
• Staining and Labeling 5%
• Biopsy 4%
• Drug Therapy 4%
• Mutation 4%
• Antibodies 4%
• Therapeutics 1%